Ruggero Fariello

Corporate Officer/Principal bei SeneXta Therapeutics SA

81 Jahre

Health Technology

Consumer Services

Retail Trade

Aktive Positionen von Ruggero Fariello

Unternehmen	Position	Beginn	Ende
SeneXta Therapeutics SA SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland.	Corporate Officer/Principal	18.09.2009	-

Unternehmen	Position	Beginn	Ende
NEWRON PHARMACEUTICALS S.P.A.	Direktor/Vorstandsmitglied	01.01.1999	21.05.2007
	Gründer	01.01.1999	21.05.2007
	Independent Dir/Board Member	01.01.1999	21.05.2007
Neurotune AG Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland.	Technik-/Wissenschafts-/F&E-Leiter	04.11.2009	20.02.2013
	Corporate Officer/Principal	20.02.2013	-
Thomas Jefferson University	Technik-/Wissenschafts-/F&E-Leiter	18.09.2009	-
Pharmacia & Upjohn, Inc.	Corporate Officer/Principal	-	-
CNS, Inc. (Delaware) CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN.	Technik-/Wissenschafts-/F&E-Leiter	-	-
Rush University	Vorsitzender	-	-

University of Turin

Doctorate Degree

International

Operativ

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	3
Chairman	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
NEWRON PHARMACEUTICALS S.P.A.	Health Technology

Private Unternehmen	4
SeneXta Therapeutics SA SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland.	Health Technology
CNS, Inc. (Delaware) CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN.	Retail Trade
Pharmacia & Upjohn, Inc.	Health Technology
Neurotune AG Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland.	Health Technology